FLEXION THERAPEUTICS INC's ticker is FLXN and the CUSIP is 33938J106. A total of 133 filers reported holding FLEXION THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $750,000 | -18.1% | 72,072 | +3.4% | 0.05% | -18.8% |
| Q2 2020 | $916,000 | +62.7% | 69,711 | -2.6% | 0.06% | +52.4% |
| Q1 2020 | $563,000 | -55.7% | 71,575 | +16.5% | 0.04% | -44.0% |
| Q4 2019 | $1,272,000 | +53.6% | 61,449 | +1.6% | 0.08% | +47.1% |
| Q3 2019 | $828,000 | +4.5% | 60,475 | -6.2% | 0.05% | +2.0% |
| Q2 2019 | $792,000 | -21.0% | 64,448 | -19.8% | 0.05% | -21.9% |
| Q1 2019 | $1,002,000 | -4.7% | 80,348 | -13.5% | 0.06% | -11.1% |
| Q4 2018 | $1,051,000 | -41.4% | 92,877 | -3.2% | 0.07% | -31.4% |
| Q3 2018 | $1,795,000 | -36.3% | 95,965 | -12.0% | 0.10% | -23.9% |
| Q2 2018 | $2,817,000 | -2.5% | 109,003 | -15.5% | 0.14% | +2.2% |
| Q1 2018 | $2,889,000 | -9.2% | 128,924 | +1.4% | 0.14% | +3.8% |
| Q4 2017 | $3,182,000 | +6.2% | 127,104 | +2.6% | 0.13% | +2.4% |
| Q3 2017 | $2,996,000 | – | 123,904 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 3,842,578 | $40,001,000 | 7.32% |
| MILLER VALUE PARTNERS, LLC | 5,274,439 | $54,907,000 | 1.97% |
| Mesirow Financial Investment Management, Inc. | 32,371 | $337,000 | 1.44% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,068,580 | $11,124,000 | 1.25% |
| Clearline Capital LP | 399,159 | $4,155,000 | 1.09% |
| CLOUGH CAPITAL PARTNERS L P | 1,246,150 | $12,972,000 | 0.93% |
| Novo Holdings A/S | 1,403,370 | $14,609,000 | 0.72% |
| SNOW CAPITAL MANAGEMENT LP | 303,265 | $3,157,000 | 0.63% |
| AMERICAN FINANCIAL GROUP INC | 317,700 | $3,308,000 | 0.46% |
| Granahan Investment Management | 1,257,690 | $13,093,000 | 0.44% |